Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin
Pedro Torres-ayuso, Sudhakar Sahoo, Garry Ashton, Elvira An, Nicole Simms, Melanie Galvin, Hui Sun Leong, Kristopher K Frese, Kathryn Simpson, Natalie Cook, Andrew Hughes, Crispin J Miller, Richard Marais, Caroline Dive, Matthew G Krebs, John Brognard
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin'. Together they form a unique fingerprint.